Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas S Duesbery

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Molecular Cancer Therapeutics|March 6, 2008
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcomaYan Ding, Elissa A Boguslawski, Bree D Berghuis, et al.
American Journal of Medical Genetics. Part A|March 27, 2015
Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterationsJacqueline D Peacock, Karl J Dykema, Helga V Toriello, et al.
Molecular Cancer Therapeutics|June 28, 2013
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcomaNicholas J Andersen, Brian J Nickoloff, Karl J Dykema, et al.
American Journal of Cancer Research|June 24, 2015
Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanismsDavid J Monsma, David M Cherba, Emily E Eugster, et al.
Plos Genetics|September 7, 2018
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysisWilliam P D Hendricks, Victoria Zismann, Karthigayini Sivaprakasam, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Molecular Cancer Therapeutics|March 6, 2008
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcomaYan Ding, Elissa A Boguslawski, Bree D Berghuis, et al.
American Journal of Medical Genetics. Part A|March 27, 2015
Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterationsJacqueline D Peacock, Karl J Dykema, Helga V Toriello, et al.
Molecular Cancer Therapeutics|June 28, 2013
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcomaNicholas J Andersen, Brian J Nickoloff, Karl J Dykema, et al.
American Journal of Cancer Research|June 24, 2015
Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanismsDavid J Monsma, David M Cherba, Emily E Eugster, et al.
Plos Genetics|September 7, 2018
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysisWilliam P D Hendricks, Victoria Zismann, Karthigayini Sivaprakasam, et al.
Pageof 4